Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion type Assertion NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_head.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion description "[Subsets with `CLL-biased` homologous complementarity-determining region 3 (CDR3) were identified: (1) IGKV2-30-IGKJ2, 7 sequences with homologous kappa CDR3 (KCDR3), 5 of 7 associated with homologous IGHV4-34 heavy chains; (2) IGKV1-39/1D-39-IGKJ1/4, 4 unmutated sequences with homologous KCDR3, 2 of 4 associated with homologous IGHV4-39 heavy chains; (3) IGKV1-5-IGKJ1/3, 4 sequences with homologous KCDR3, 2 of 4 associated with unmutated nonhomologous IGHV4-39 heavy chains; (4) IGLV1-44-IGLJ2/3, 2 sequences with homologous lambda CDR3 (LCDR3), associated with homologous IGHV4-b heavy chains; and (5) IGLV3-21-IGLJ2/3, 9 sequences with homologous LCDR3, 3 of 9 associated with homologous IGHV3-21 heavy chains.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_provenance.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion evidence source_evidence_literature NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_provenance.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion SIO_000772 16076869 NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_provenance.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion wasDerivedFrom befree-20140225 NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_provenance.
- NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_assertion wasGeneratedBy ECO_0000203 NP255922.RAsL8IFhoMGxxIWNoSRczxdn-yFAcOydFYXJ0F1Lo1KKE130_provenance.